视黄酸

CAS号
302-79-4 ;69877-38-9
CCD编号
CCD00001517
分子式
C20H28O2
分子量
300.439

基本信息

产品名称: 视黄酸
CAS: 302-79-4 ;69877-38-9
中文同义词: 维甲酸 ; 维他命A酸 ; 3,7-二甲基-9-(2,6,6-三甲基环己烯)-2,4,6,8-全反式壬四烯酸 ; 维A酸 ; 维生素A酸 ; 视黄酸
英文同义词: RENOVA ; VITAMIN A ACID, ALL-TRANS ; ALL-TRANS-RETINOIC ACID, USP 98.0-102.0% ; RETINOIC ACID ALL TRANS ISOMER ; AVITA ; RO 1-5488 ; TRETINOIN VITAMIN A ACID ; AIROL ; (2E,4E,6E,8E)-3,7-DIMETHYL-9-(2,6,6-TRIMETHYLCYCLOHEX-1-EN-1-YL)NONA-2,4,6,8-TETRAENOIC ACID ; ALL-TRANS-VITAMIN A ACID ; RETACNYL ; 3,7-DIMETHYL-9-(2,6,6-TRIMETHYL-1-CYCLOHEXEN-1-YL)-2E,4E,6E,8E-NONATETRAENOIC ACID ; ABEREL ; ATTERCOP-CHM AT116707 ; RETINOVA ; (ALL-E)-3,7-DIMETHYL-9-(2,6,6-TRIMETHYL-1-CYCLOHEXEN-1-YL)-2,4,6,8-NONATETRAENOIC ACID ; AV ; RETINOIC ACID ; ATRALIN ; VITAMIN A ACID ; RETINOIC ACID, ALL TRANS ; VESANOID ; ALL-TRANS-RETINOIC ACID ; RETIONOIC ACID ; 9-TRANS-TRETINOIN ; RENNOTECH RP17637 ; TRETINOIN, USP 98.0-102.0% ; RETIN-A ; 9-TRANS-RETINOIC ACID ; TRANS-RETINOIC ACID ; TIMTEC-BB SBB065722 ; ATRA ; PARAGOS 50002 ; 3,7-DIMETHYL-9-(2,6,6-TRIMETHYL-1-CYCLOHEXEN-1-YL)-2,4,6,8-NONATETRAENOIC ACID ; TRETINOIN
MDL号: MFCD00001551
氢键受体数量: 2
氢键供体数量: 1
Smile: C\C(\C=C\C1=C(C)CCCC1(C)C)=C/C=C/C(/C)=C/C(O)=O
InChi: InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14+
InChiKey: InChIKey=SHGAZHPCJJPHSC-YCNIQYBTSA-N

性质

熔点: 180-181 DEG C(LIT)
注解: BIOCHEM/PHYSIOL ACTIONS: ALL-TRANS-RETINOIC ACID (ATRA) IS A LIGAND FOR BOTH THE RETINOIC ACID RECEPTOR (RAR) AND THE RETINOID X RECEPTOR (RXR). THE BOUND RAR AND RXR ACT AS TRANSCRIPTION FACTORS THAT REGULATE THE GROWTH AND DIFFERENTIATION OF BOTH NORMAL AND MALIGNANT CELLS. CYTOCHROMES P450 (CYPS) CATALYZE THE 4-HYDROXYLATION OF ATRA. RETINOIC ACID PRIMES EMBRYONIC STEM CELLS TO BECOME NEURONS
GENERAL DESCRIPTION: THIS PRODUCT IS PROVIDED AS DELIVERED AND SPECIFIED BY THE ISSUING PHARMACOPOEIA. ALL INFORMATION PROVIDED IN SUPPORT OF THIS PRODUCT, INCLUDING MSDS AND ANY PRODUCT INFORMATION LEAFLETS HAVE BEEN DEVELOPED AND ISSUED UNDER THE AUTHORITY OF THE ISSUING PHARMACOPOEIA. FOR FURTHER INFORMATION AND SUPPORT PLEASE GO TO THE WEBSITE OF THE ISSUING PHARMACOPOEIA
OTHER NOTES: SALES RESTRICTIONS MAY APPLY

安全信息

符号: GHS07 GHS07
信号词: Warning
危险声明: H302
危害码: Xn
风险声明: R:22
安全声明: S:61
WGK德国: 2

* If the product has intellectual property rights, a license granted is must or contact us.